Resultados de la búsqueda 1121-1130 of 6271 for decrease application based

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    A reduction in margins is expected to improve quality of life to back up ... Android App on Google Play · Apple Download on the App Store · Términos y ...

  2. Oncología (médica) - Ensayos clínicos

    This may lead to an increased risk of serious infections requiring hospitalization and an increased risk of secondary non-blood-based (hematologic) cancers.

  3. Ensayos clínicos - Neurología

    ... decline (e.g., Mueller et al, 2018). We propose to add a series of in-clinic ... Android App on Google Play · Apple Download on the App Store · Términos y ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... decrease inflammatory cytokines (11) and decrease ... Recently, the EDII was developed and validated to assess inflammatory potential of diet based on the Food ...

  5. Ensayos clínicos - Medicina cardiovascular

    The purpose of this study is to analyze the effectiveness and safety of an embolic protection device compared to a standard aortic cannula to reduce the ...

  6. Medicina interna general - Ensayos clínicos

    Rochester, Minn. The purpose of this study is test the effectiveness of the senolytic drug (Fisetin) in reducing senescent cell abundance in blood in elderly ...

  7. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

    The postnatal diagnosis of Long QT Syndrome (LQTS) is suggested by a prolonged QT interval on 12 lead electrocardiogram (ECG),a positive family history ...

  8. Psiquiatría y psicología - Ensayos clínicos

    The purpose of this study is to pilot test the ENHANCE intervention to evaluate methodology, feasibility based on caregiver input, and preliminary caregiver ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Given the fact that the effects of over-the-counter probiotics in reducing the risks of IIC remains largely unknown. ... Android App on Google Play · Apple ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...